Overview

Clinical trials are carefully designed experiments that allow scientists to test their research questions on people. They are a logical, structured way to answer questions about how to prevent, treat and cure HIV or complications associated with HIV/AIDS. Clinical trials are the most effective way for scientists to assess whether the benefits of a particular treatment outweigh its risks, and if it will improve the lives of people living with HIV.

Importance of Clinical Trials

Findings in clinical research, including studies on treatments, are helping people with HIV live longer, with improvements in quality of life that were not possible ten, five or even two years ago. People living with HIV play a particularly key role in research. They help to ensure that researchers are aware of their needs and concerns, and as participants, they give researchers the scientific information required to develop treatments.

About Clinical Trials

Participating in a Clinical Trial

Once You’re Enrolled

Other Things to Consider

Clinical Trials Handbook

The material found on this site is also available as a booklet called Clinical Trials: What you need to know published by the CIHR Canadian HIV Trials Network in partnership with the Canadian AIDS Society.

Written in plain language for people living with HIV, and their families and friends, the popular booklet provides a wealth of basic information about clinical trials in a simple question-and-answer format. Chapters discuss the design of trials, how to decide whether to participate, stages of participation and other issues such as the responsibilities of volunteers, what happens if participants become ill, and the use of other drugs.

For free print copies call us at 1-800-661-4664 or email ctninfo@hivnet.ubc.ca.

Download

Latest News

The enigma of HIV’s effects on aging

| Uncategorized | No Comments

The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.

Guest Blog: Dr. Haneesha Mohan

| Uncategorized | No Comments

Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.

Let’s Talk About Stigma: HIV in 2020

| Uncategorized | No Comments

We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it

Could Cannabis Help Prevent HIV-Related Illnesses?

| Uncategorized | No Comments

CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation